City and Hackney: Change in method for receiving results for Latent TB screening (T-Spot results)

Posted on:

City and Hackney practices have been receiving T-Spot (Latent blood test) results via path links into EMIS alongside other test results from Barts/Homerton Pathology Lab. Due to operational issues at the Lab, the T-Spot results will no longer be reported by the Lab in this way.  Revvity (previously known as Oxford Immunotec) will be reporting all T-Spot results to practices via practices’ generic inboxTo ensure a seamless transition and safeguard receipt of urgent results, the pathology lab will be reporting positive/borderline positive/borderline negative T-Spot results via path links until 1st May 2024. Thereafter, this will method of receipt of results will cease. 

What should practices do next?

  • Inform all colleagues,  particularly Administrators who code results,  of the new reporting pathway and follow usual practice process for actioning test results
  • Results received from  Revvity to the practice generic inbox must be coded onto the patient EMIS record using the following codes on the ‘RP Latent TB’ template:
    • Code Interferon Gamma Assay negative (IGRA) for negative/borderline negative results
    • Code Interferon Gamma Assay positive (IGRA) for positive /borderline positive results
    • Code Interferon Gamma Assay indeterminate (IGRA) results (patient to be retested by practice after 6 – 8 weeks)
  • The Revvity PDF results report must also be saved into the patient EMIS record
  • Remember, positive/borderline positive results must be referred to the Respiratory Team, TB Clinic via E-RS

If you have any management queries regarding this, please contact Helen Crane, helen.crane1@nhs.net or Ansley Magwaza, ansley.magwaza@nhs.net

This website is for healthcare professions only.

It is not for public use.

Feedback
Feedback
How would you rate your experience?
Do you have any additional comment?
Next
Enter your email if you'd like us to contact you regarding with your feedback.
Back
Submit
Thank you for submitting your feedback!